Replies to post #705999 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

NWBO did adhere to the patient patient-level data. as set by the FDA.,,

Per the JAMA paper:

This study has limitations. Since individual patient-level data for the ECPs were not available for this trial, as is often the case, propensity score matching could not be performed, which is a potential limitation of this study.

[exwannabe]

You just posted a statement that individual patient level data for the ECA is required, and NWBO has made clear they do do have it.

I will be glad to see you gone by end of year.,